Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2
John P. Evans, Cong Zeng, Panke Qu, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 8, pp. 1093-1102.e3
Open Access | Times Cited: 128

Showing 76-100 of 128 citing articles:

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sub-Lineages BA.1 and BA.2
Lia Fiaschi, Filippo Dragoni, Elisabetta Schiaroli, et al.
(2022)
Open Access | Times Cited: 9
Unraveling the tapestry: Immune imprinting amidst a spectrum of challenges for modRNA Covid-19 vaccines
Ronald Palacios Castrillo
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 25-28
Open Access | Times Cited: 1
SARS-CoV-2 BA.4/5 infection triggers more cross-reactive FcγRIIIa signaling and neutralization than BA.1, in the context of hybrid immunity
Simone I. Richardson, Nonkululeko Mzindle, Thopisang Motlou, et al.
Journal of Virology (2024) Vol. 98, Iss. 7
Closed Access | Times Cited: 1
Integrated All-Atom and Coarse-Grained Simulations Uncover Structural, Dynamics and Energetic Shifts in SARS-CoV-2 JN.1 and BA.2.86 Variants
Amreeta Sharma, Shweata Maurya, Timir Tripathi, et al.
Acta Tropica (2024) Vol. 260, pp. 107444-107444
Closed Access | Times Cited: 1
Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
Manon Vogrig, Anne‐Emmanuelle Berger, Thomas Bourlet, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 31-45
Open Access | Times Cited: 8
Omicron BA.1 breakthrough infection drives long-term remodeling of the memory B cell repertoire in vaccinated individuals
Aurélien Sokal, Giovanna Barba‐Spaeth, Lise Hunault, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
Guinevere G. Connelly, Orville O. Kirkland, Seven Bohannon, et al.
Cell Reports Methods (2022) Vol. 2, Iss. 8, pp. 100273-100273
Open Access | Times Cited: 7
Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
Panke Qu, John P. Evans, Yi-Min Zheng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Post-vaccination neutralization responses to Omicron sub-variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
Panke Qu, John P. Evans, Chaitanya Kurhade, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Effectiveness of a Third Dose of COVID-19 mRNA Vaccine During the Omicron BA.1- and BA.2-Predominant Periods in Japan: The VENUS Study
Wataru Mimura, Chieko Ishiguro, Megumi Maeda, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 6
Serological and Molecular Surveillance for SARS-CoV-2 Infection in Captive Tigers (Panthera tigris), Thailand
Nareerat Sangkachai, Somjit Chaiwattanarungruengpaisan, Metawee Thongdee, et al.
Animals (2022) Vol. 12, Iss. 23, pp. 3350-3350
Open Access | Times Cited: 6
Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1741-1761
Open Access | Times Cited: 3
An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation
Seoryeong Park, Jaewon Choi, Yonghee Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
José Valter Joaquim Silva Júnior, Ricardo Durães‐Carvalho, Joelma Rodrigues de Souza, et al.
Virology (2023) Vol. 585, pp. 78-81
Open Access | Times Cited: 3
SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region
Sevan Omer Majed, Suhad Asad Mustafa, Paywast Jamal Jalal, et al.
Genes (2023) Vol. 14, Iss. 1, pp. 173-173
Open Access | Times Cited: 2
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia
Rossana Scutari, Valeria Fox, Maria Antonietta De Ioris, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
A retrospective analysis of clinical features of patients hospitalized with SARS-CoV-2 Omicron variants BA.1 and BA.2
Cristina Groza, David Totschnig, Christoph Wenisch, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
Ying Chen, Caiqin Hu, Zheng Wang, et al.
(2023)
Open Access | Times Cited: 2
Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces
Ya‐Wen Hsiao, David J. Bray, Tseden Taddese, et al.
Biophysical Journal (2023) Vol. 122, Iss. 20, pp. 4057-4067
Open Access | Times Cited: 2
Delineating the Structure–Dynamics–Binding Differences among BA.1, BA.4/5, and BF.7 SARS-CoV-2 Variants through Atomistic Simulations: Correlation with Structural and Epidemiological Features
Aryaman Joshi, Shweata Maurya, Atharva Mahale, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 37852-37863
Open Access | Times Cited: 2
Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
Ying Chen, Caiqin Hu, Zheng Wang, et al.
Pathogens (2023) Vol. 12, Iss. 10, pp. 1254-1254
Open Access | Times Cited: 2
Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/ Iraq
Sevan Omer Majed, Paywast Jamal Jalal, Mohammed Hassan Fatah, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 11, pp. 56-63
Open Access | Times Cited: 2
Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Liang Hong, Xuanxuan Nian, Junzheng Wu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 4

Scroll to top